Cointime

ARGOBIO

company

About

Argobio is a start-up studio for therapeutics aiming to nurture and launch biotech companies.

Highlights

Total Funding Amount
€50M
Funding Rounds
1
Investors
4
Employee Profiles
3

Details

Last Funding Type
Funding Round
Last Funding Money Raised
€50M
Industries
Biotechnology
Founded date
Jan 1, 2021
Number Of Employee
1 - 10
Operating Status
Active
Legal Name
Argobio SAS

Argobio is a start-up studio devoted to developing unique therapeutic solutions, with the purpose of nurturing and launching revolutionary biotech firms. It sources cutting-edge early-stage projects from leading European academic research institutes in order to cultivate and nurture these projects before launching companies. The main focus is on rare diseases, neurological issues, oncology, and immunology. Additionally, the studio is looking to create promising platform technologies for therapeutic products.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€50M
ARGOBIO has raised a total of €50M in funding over 2 rounds. Their latest funding was raised on Mar 2, 2021 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 2, 2021 Funding Round €50M 4 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
4
ARGOBIO is funded by 4 investors. Evotec and Bpifrance are the most recent investors.
Investor Name Lead Investor Funding Round
Evotec — Funding Round
Bpifrance — Funding Round
Kurma Partners — Funding Round
Pasteur Institute — Funding Round

Employee Profiles

Number of Employee Profiles
3
ARGOBIO has 3 current employee profiles, including Executive Remi Soula
Remi Soula
Executive
Daniel Sobral
Executive
Cointime
Content
Company